Syros Pharmaceuticals, Inc.【SYRS】 財務キャッシュフローの推移
機能の使い方
|
(単位:千ドル)
|
財務キャッシュフロー
|
前年比(%)
|
|
3Q24
|
0
|
-100.0%
|
|
2Q24
|
41
|
-70.7%
|
|
1Q24
|
-265
|
+400.0%
|
|
4Q23
|
43,380
|
-505.3%
|
|
3Q23
|
-5
|
-100.0%
|
|
2Q23
|
140
|
-163.1%
|
|
1Q23
|
-53
|
-43.0%
|
|
4Q22
|
-10,703
|
-11249.0%
|
|
3Q22
|
142,063
|
-212134.3%
|
|
2Q22
|
-222
|
-408.3%
|
|
1Q22
|
-93
|
-100.1%
|
|
4Q21
|
96
|
-99.9%
|
|
3Q21
|
-67
|
-128.4%
|
|
2Q21
|
72
|
-67.3%
|
|
1Q21
|
70,410
|
+122.2%
|
|
4Q20
|
110,804
|
+10074.8%
|
|
3Q20
|
236
|
-2066.7%
|
|
2Q20
|
220
|
-99.7%
|
|
1Q20
|
31,693
|
-27659.1%
|
|
4Q19
|
1,089
|
+694.9%
|
|
3Q19
|
-12
|
-103.7%
|
|
2Q19
|
65,028
|
+295.2%
|
|
1Q19
|
-115
|
-100.2%
|
|
4Q18
|
137
|
-80.2%
|
|
3Q18
|
327
|
-1154.8%
|
|
2Q18
|
16,453
|
-
|
|
1Q18
|
52,167
|
+40655.5%
|
|
4Q17
|
692
|
+2783.3%
|
|
3Q17
|
-31
|
-100.1%
|
|
1Q17
|
128
|
-
|
|
4Q16
|
24
|
-
|
|
3Q16
|
52,730
|
-
|